NO940020L - - Google Patents

Info

Publication number
NO940020L
NO940020L NO940020A NO940020A NO940020L NO 940020 L NO940020 L NO 940020L NO 940020 A NO940020 A NO 940020A NO 940020 A NO940020 A NO 940020A NO 940020 L NO940020 L NO 940020L
Authority
NO
Norway
Prior art keywords
alkyl
cycloalkyl
represent
products
cor4
Prior art date
Application number
NO940020A
Other languages
English (en)
Norwegian (no)
Other versions
NO940020D0 (no
NO300839B1 (no
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NO940020D0 publication Critical patent/NO940020D0/no
Publication of NO940020L publication Critical patent/NO940020L/no
Publication of NO300839B1 publication Critical patent/NO300839B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO940020A 1993-01-05 1994-01-04 Nye 2-cyano-3-hydroksy-propenamider og farmasöytiske preparater inneholdende slike NO300839B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939300083A GB9300083D0 (en) 1993-01-05 1993-01-05 Chemical compounds

Publications (3)

Publication Number Publication Date
NO940020D0 NO940020D0 (no) 1994-01-04
NO940020L true NO940020L (zh) 1994-07-06
NO300839B1 NO300839B1 (no) 1997-08-04

Family

ID=10728304

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940020A NO300839B1 (no) 1993-01-05 1994-01-04 Nye 2-cyano-3-hydroksy-propenamider og farmasöytiske preparater inneholdende slike

Country Status (33)

Country Link
US (1) US5346912A (zh)
EP (1) EP0606175B1 (zh)
JP (1) JP3334988B2 (zh)
KR (1) KR100295717B1 (zh)
CN (1) CN1042935C (zh)
AT (1) ATE128968T1 (zh)
AU (1) AU663017B2 (zh)
BR (1) BR9400017A (zh)
CA (1) CA2112866C (zh)
CZ (1) CZ283948B6 (zh)
DE (1) DE69400024T2 (zh)
DK (1) DK0606175T3 (zh)
EE (1) EE03001B1 (zh)
ES (1) ES2078130T3 (zh)
FI (1) FI106553B (zh)
GB (1) GB9300083D0 (zh)
GR (1) GR3017723T3 (zh)
HR (1) HRP940006B1 (zh)
HU (1) HU216835B (zh)
IL (1) IL107788A (zh)
LT (1) LT3766B (zh)
LV (1) LV10712B (zh)
MX (1) MX9400274A (zh)
NO (1) NO300839B1 (zh)
NZ (1) NZ250520A (zh)
PL (1) PL175135B1 (zh)
RU (1) RU2126387C1 (zh)
SI (1) SI9300686A (zh)
SK (1) SK280508B6 (zh)
TW (1) TW259785B (zh)
UA (1) UA40573C2 (zh)
YU (1) YU49047B (zh)
ZA (1) ZA939118B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002521441A (ja) * 1998-07-28 2002-07-16 スミスクライン・ビーチャム・コーポレイション Ccr5モジュレーターとしてのプロペンアミド
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
WO2009027393A2 (en) 2007-08-27 2009-03-05 Basf Se Pyrazole compounds for controlling invertebrate pests
PL2342196T3 (pl) 2008-09-24 2015-12-31 Basf Se Związki pirazolowe do zwalczania szkodników będących bezkręgowcami
WO2011003793A1 (en) 2009-07-06 2011-01-13 Basf Se Pyridazine compounds for controlling invertebrate pests
WO2011003796A1 (en) 2009-07-06 2011-01-13 Basf Se Pyridazine compounds for controlling invertebrate pests
CN102469785A (zh) 2009-07-24 2012-05-23 巴斯夫欧洲公司 防治无脊椎动物害虫的吡啶衍生物
EA201691057A1 (ru) 2013-11-22 2016-10-31 Джензим Корпорейшн Новые способы лечения нейродегенеративных заболеваний
CN105693574B (zh) * 2014-11-25 2017-12-19 中国科学院大连化学物理研究所 2‑烷硫基烯酰胺衍生物及其合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4435407A (en) * 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
DE3534440A1 (de) 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US4888357A (en) 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
IL92508A0 (en) * 1988-12-08 1990-08-31 Ciba Geigy Ag Novel alpha-cyano-beta-oxopropionamides
EP0527736B1 (de) * 1990-05-18 1997-04-16 Hoechst Aktiengesellschaft Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide

Also Published As

Publication number Publication date
ES2078130T3 (es) 1995-12-01
NO940020D0 (no) 1994-01-04
CN1097005A (zh) 1995-01-04
YU49047B (sh) 2003-07-07
DE69400024T2 (de) 1996-04-04
HU9400033D0 (en) 1994-05-30
HU216835B (hu) 1999-09-28
KR940018363A (ko) 1994-08-16
LV10712B (en) 1995-12-20
MX9400274A (es) 1994-08-31
BR9400017A (pt) 1994-08-02
GB9300083D0 (en) 1993-03-03
RU94000064A (ru) 1996-07-10
TW259785B (en) 1995-10-11
EP0606175A1 (fr) 1994-07-13
ZA939118B (en) 1995-01-18
CZ283948B6 (cs) 1998-07-15
US5346912A (en) 1994-09-13
LTIP1634A (en) 1995-02-27
FI940031A0 (fi) 1994-01-04
LV10712A (lv) 1995-06-20
HRP940006B1 (en) 1999-12-31
LT3766B (en) 1996-03-25
HRP940006A2 (en) 1996-10-31
SK280508B6 (sk) 2000-03-13
JPH06211793A (ja) 1994-08-02
FI106553B (fi) 2001-02-28
EP0606175B1 (fr) 1995-10-11
PL301774A1 (en) 1994-07-11
NZ250520A (en) 1996-08-27
ATE128968T1 (de) 1995-10-15
IL107788A (en) 1998-08-16
AU5213093A (en) 1994-07-14
SI9300686A (en) 1994-09-30
AU663017B2 (en) 1995-09-21
GR3017723T3 (en) 1996-01-31
KR100295717B1 (ko) 2001-11-05
CA2112866A1 (fr) 1994-07-06
RU2126387C1 (ru) 1999-02-20
YU82593A (sh) 1996-07-24
IL107788A0 (en) 1994-02-27
DE69400024D1 (de) 1995-11-16
FI940031A (fi) 1994-07-06
CN1042935C (zh) 1999-04-14
HUT71471A (en) 1995-11-28
NO300839B1 (no) 1997-08-04
CA2112866C (fr) 2007-03-13
SK149593A3 (en) 1994-12-07
JP3334988B2 (ja) 2002-10-15
DK0606175T3 (da) 1996-02-19
UA40573C2 (uk) 2001-08-15
CZ292193A3 (en) 1994-07-13
PL175135B1 (pl) 1998-11-30
EE03001B1 (et) 1997-06-16

Similar Documents

Publication Publication Date Title
TW237455B (zh)
TW234120B (zh)
NO940020L (zh)
FI955430A (fi) Bisyklisiä amidijohdannaisia ja niiden käyttö lihasten jännitystä laukaisevina aineena
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
ID23053A (id) Karboksamida yang digunakan sebagai agonis 5-ht <if>
EP1031556A4 (en) 2-PHENOXYANILINE DERIVATIVES
FI962587A (fi) 1,3-oksatsin-4-onijohdannaiset, menetelmä ja välituotteet niiden valmistamiseksi ja niiden käyttö herbisideinä
GB9202139D0 (en) Improvements in or relating to organic compounds
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ES2059928T3 (es) Ciclopropanotiocarboxiamidas.

Legal Events

Date Code Title Description
MK1K Patent expired